Fevzi BEDİR, Banu BEDİR, Hüseyin KOCATÜRK, Mehmet Sefa ALTAY

Covid-19 (Sars-CoV-2) salgını sırasında uygulanan robot yardımlı radikal prostatektominin güvenilirliği: Bir pandemi hastanesinin deneyimleri

GİRİŞ ve AMAÇ: Covid-19 pandemisi sürecinde prostat kanseri (PCa) sebebi ile robot yardımlı radikal prostatektomi (RARP) yapılan hastaların sonuçlarını ve deneyimlerimizi sunmayı amaçladık. YÖNTEM ve GEREÇLER: Türkiye Cumhuriyeti Sağlık Bakanlığı ve kurumsal etik onayı (37732058-514.10-2020/19- 184) sonrasında Covid-19 döneminde (11 Mart 2020-10 Ağustos 2020) RARP uygulanan hastalar retrospektif olarak aşaştırıldı. Covid-19'un erken döneminde, hastanemiz pandemi hastanesi ilan edildi ve cerrahi müdahaleler için çeşitli önlemler belirlendi. 15 Ağustos 2020 tarihinden sonra hastanemizde covid-19 vakalarının yükü nedeniyle tüm cerrahi işlemler askıya alındı. Cerrahi işlem uygulanan hastalar tek kişilik odalarda tutuldu ve refakatçileri kısıtlandı. Hastalara ameliyat öncesi covid 19 real time PCR testi uygulandı. Bu süreçte tüm işlemler Avrupa Üroloji Derneği covid 19 cerrahi prosedürleri dikkate alınarak yapıldı. BULGULAR: Toplmada 12 hasta çalışmaya dahil edildi. Hastaların yaş ortalaması 62.08±6.57 yıl, vücut kitle indeksi (BMI) 28.58±3.37 kg/m2, Serum PSA 7.24±1.86 ng/mL, prostat volümü 124.83±50.06 cc idi. Tüm hastaların biyopsi gleason skoru 3+3=6 olarak raporlandı. Ortalama takip süresi 3.67 aydı. Hiçbir hastada cerrahi komplikasyon ve covid 19 görülmedi. Hiçbir hastada kimyasal nüks görülmedi. TARTIŞMA ve SONUÇ: Covid 19 pandemisinin geleceği tahmin edilemediği için, RARP çeşitli önlemler ve uygun prosedürlerle güvenle uygulanabilir.

The reliability of robot-assisted radical prostatectomy applied during the Covid-19 (Sars-CoV-2) pandemic: The experience of a pandemic hospital

INTRODUCTION: In this study we aimed to present the results of patients undergoing robot-assisted radical prostatectomy (RARP) due to prostate cancer (PCa), and our own experience, during the Covid-19 pandemic. METHODS: Following receipt of approval from the Turkish Ministry of Health and the institutional ethical committee (37732058-514.10-2020/19-184), patients who had undergone RARP during the Covid-19 pandemic (11 March to 10 August 2020) were investigated retrospectively. Our institution was declared to be a pandemic hospital in the early period of Covid-19, and various precautionary measures were introduced for surgical interventions. Due to the burden of Covid-19 cases in our hospital, all surgical procedures were postponed after 15 August, 2020. Patients undergoing surgical procedures were housed in single-occupancy rooms, and restrictions were placed on accompanying individuals. The Covid-19 real-time PCR test was performed before surgery. During this period, all procedures were performed in compliance with European Assocıatıon of Urology Covid-19 surgical procedures. RESULTS: Twelve patients were included in the study. The patients’ mean age was 62.08±6.57 years, and their mean body mass index (BMI) was 28.58±3.37 kg/m2, mean serum was PSA 7.24±1.86 ng/mL, and mean prostate volume was 124.83±50.06 cc. All patients’ biopsy Gleason scores were reported as 3+3=6. The mean follow-up period was 3.67 months. No surgical complications of Covid-19 were observed in any patient. No chemical occurrence also occurred in any patient. DISCUSSION AND CONCLUSION: Since the future of the Covid-19 pandemic is unpredictable, RARP can be safely performed with various precautionary measures and appropriate procedures.

PDF

___

1. Park SE. Epidemiology, virology, and clinical features of severe acute respiratory syndrome - coronavirus-2 (SARS-CoV-2; Coronavirus Disease19). Clin Exp Pediatr 2020;63:119-24.
2. World Health Organization. WHO Timeline - COVID-19. World Health Organization. Available from: https://www.who.int/news-room/detail/08-04- 2020-who-timeline-covid-19May 21, 2020.
3. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. COVID-19 (SARS-CoV-2 Enfeksiyonu) Rehberi Bilim Kurulu Çalışması. Available from: https://covid19bilgi.saglik.gov.tr/depo/rehberler/CO VID-19_Rehberi.pdf. May 21, 2020.
4. Rawla P. Epidemiology of Prostate Cancer. World J Oncol 2019;10:63-89.
5. Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol 2019;5:1749-68.
6. Naspro R, Da Pozzo LF. Urology in the time of corona. Nat Rev Urol 2020;17:251-3. 7. Campi R, Amparore D, Capitanio U, Checcucci E, Salonia A, Fiori C, et al. Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID19 Pandemic: Insights from Three Italian Highvolume Referral Centres. Eur Urol 2020;78:11-5.
8. Ficarra V, Novara G, Abrate A, Bartoletti R, Crestani A, De Nunzio C, et al. Urology practice during the COVID-19 pandemic. Minerva Urol Nefrol 2020;72:369-75.
9. Heldwein FL, Loeb S, Wroclawski ML, Sridhar AN, Carneiro A, Lima FS, et al. A Systematic Review on Guidelines and Recommendations for Urology Standard of Care During the COVID-19 Pandemic. Eur Urol Focus 2020;6:1070-85.
10.Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270-3.
11.Zumla A, Niederman MS. The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security. Current Opinion in Pulmonary Medicine 2020.
12.Tan WS, Arianayagam R, Khetrapal P, Rowe E, Kearley S, Mahrous A, et al. Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic: A Multicentre Analysis of 30-day Outcomes. Eur Urol Open Sci 2021.
13.Ribal MJ, Cornford P, Briganti A, Knoll T, Gravas S, Babjuk M, et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol 2020;78:21-8.
14.Moschovas MC, Bhat S, Rogers T, Onol F, Roof S, Sighinolfi MC, et al. Managing Patients with Prostate Cancer During COVID-19 Pandemic: The Experience of a High-Volume Robotic Surgery Center. J Endourol 2020.
15.Sean Ong XR, Condon B, Bagguley D, Lawrentschuk N, Azad A, Murphy D. Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19. Future Oncol 2020;16:1409-11.
16.Bokhorst LP, Valdagni R, Rannikko A, Kakehi Y, Pickles T, Bangma CH, et al. A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment. Eur Urol 2016;70:954-60.
17.Klotz L, Vesprini D, Sethukavalan P, Jethava V, Zhang L, Jain S, et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol 2015;33:272-7.
18.Scott E, Mamawala M, Epstein JI, Landis P, Wolf S, Trock, et al. Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer. Tosoian JJ, Mamawala M, Epstein JI, Landis P, Wolf S, Trock BJ, Carter HB.J Clin Oncol. 2015 Oct 20;33(30):3379-85. [Epub 2015 Aug 31]. doi: 10.1200/JCO.2015.62.5764. Urol Oncol 2017;35:121-2.
19.Fossati N, Rossi MS, Cucchiara V, Gandaglia G, Dell'Oglio P, Moschini M, et al. Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: Can surgery be postponed safely? Urol Oncol 2017;35:150.e9-.e15.
20.Kürşat Bozkurt K, Kızmaz M, İnan Mamak G, Korkmaz İ, Bircan S. Prostat iğne biyopsisi ve radikal prostatektomi materyallerinde gleason skorlarının karşılaştırılması. Medical Journal of Suleyman Demirel University 2013;20.
21.Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. Bmj 2020;368:m1198.
22.Ti LK, Ang LS, Foong TW, Ng BSW. What we do when a COVID-19 patient needs an operation: operating room preparation and guidance. Can J Anaesth 2020;67:756-8.
23.Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med 2020;382:1199-207.
24.Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, et al. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet 2020;395:e52.
25.Soytaş M, Boz MY, Güzelburç V, Çalık G, Horuz R, Akbulut Z, et al. Comparison of before and after COVID-19 urology practices of a pandemic hospital. Turk J Urol 2020;46:474-80.